½ÃÀ庸°í¼­
»óǰÄÚµå
1596220

¼¼°èÀÇ È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Respiratory Support System Market by Indication (Asthma, Chronic Obstructive Pulmonary Disease, Infectious Diseases), Product (Consumables & Accessories, Diagnostic Devices, Monitoring Devices), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

È£Èí Áö¿ø ½Ã½ºÅÛ(Respiratory Support System) ½ÃÀåÀº 2023³â 289¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 317¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, CAGR 9.73%·Î ¼ºÀåÇßÀ¸¸ç 2030³â¿¡´Â 554¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀåÀº Æó ±â´ÉÀÌ ¼Õ»óµÈ ȯÀÚÀÇ È£Èí ±â´ÉÀ» º¸Á¶Çϰųª ´ëüÇϵµ·Ï ¼³°èµÈ ´Ù¾çÇÑ ÀåÄ¡¿Í Àåºñ¸¦ Æ÷°ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡´Â ÀΰøÈ£Èí±â, CPAP ÀåÄ¡, BiPAP ÀåÄ¡, »ê¼Ò ³óÃà±â°¡ Æ÷ÇԵǸç, °¢°¢ ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), ¼ö¸é ¹«È£ÈíÁõ, ±Þ¼ºÈ£Èí°ï¶õÁõÈıº(ARDS) µîÀÇ ÁúȯÀ¸·Î ÀÎÇÑ È£Èí ºÎÀü ¶Ç´Â ºÎÀüÀ» °ü¸®ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ Çʿ伺Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, Àα¸ °í·ÉÈ­, ÃÖ±Ù Äڷγª19¿Í °°Àº °øÁß º¸°Ç À§±â·Î ÀÎÇØ ÀÇ·á ȯ°æ¿¡¼­ È£Èí±â Áö¿ø ´É·ÂÀ» ºü¸£°Ô È®ÀåÇØ¾ß ÇÒ Çʿ伺À¸·Î ÀÎÇØ ´õ¿í ÁõÆøµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ±â±â´Â ȨÄɾî ȯ°æ, º´¿ø, ¿Ü·¡ ¼¾ÅÍ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Ȱ¿ëµÇ°í ÀÖ¾î ÃÖÁ¾ »ç¿ë ¹üÀ§°¡ ³Ð¾îÁö°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 289¾ï 2,000¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 317¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 554¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 9.73%

½ÃÀå ¼ºÀåÀº ȯÀÚ ¸ð´ÏÅ͸µ ¹× ±â±â ÀÚµ¿È­¸¦ °³¼±Çϱâ À§ÇÑ AI¿Í IoTÀÇ ÅëÇÕ°ú °°Àº ±â¼ú ¹ßÀüÀÌ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®ÀåÀº »ó´çÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ÷´Ü ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ½ÂÀÎ, Àú°³¹ß ÀÇ·á ½Ã¼³¿¡¼­ÀÇ ±â±â ÀÛµ¿ÀÇ º¹À⼺ µîÀÇ ¹®Á¦°¡ ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¼ºÀåÀ» Á¦ÇÑÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ½Å±Ô ¾÷üÀÇ ½ÃÀå ÁøÀÔÀ» ¹æÇØÇÒ ¼ö ÀÖ´Â Àå±â°£ÀÇ ½ÂÀÎ ½Ã°£°ú ȯ±Þ ¹®Á¦ µîÀÌ ÀÖ½À´Ï´Ù.

±â¼ú Çõ½Å°ú ¿¬±¸¸¦ À§ÇÑ ÃÖ¼±ÀÇ ºÐ¾ß·Î´Â ÈÞ´ë °¡´ÉÇÏ°í »ç¿ëÇϱ⠽¬¿î ÀåÄ¡ °³¹ß, ¿ø°Ý ¸ð´ÏÅ͸µÀ» À§ÇÑ ¿ø°Ý ÀÇ·á ÅëÇÕ °­È­, µ¥ÀÌÅÍ ºÐ¼® ¹× AI¸¦ ÅëÇÑ °³º°È­µÈ È£Èí±â Áö¿øÀ» Á¦°øÇÏ´Â ½Ã½ºÅÛ µðÀÚÀÎ µîÀÌ Æ÷ÇԵ˴ϴ٠ÀÌ·¯ÇÑ Çõ½ÅÀº ½ÃÀå °æÀï·ÂÀ» À¯ÁöÇÏ°í ¾Ø ¸ÞÆ®´ÏÁî¿¡ ´ëÀÀÇϱâ À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÇÏÀÌÅ×Å© ±â¾÷°úÀÇ Àü·«Àû Á¦ÈÞ´Â ÀÌ·¯ÇÑ Çõ½ÅÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¼ö¿ä°¡ ³ôÀº ºÐ¾ß¿¡¼­ Áö¼ÓÀûÀÎ ¼ºÀåÀ» º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­Çϴ ȣÈí Áö¿ø ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°Í Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • È£Èí±â ÁúȯÀÇ À¯º´·üÀÇ »ó½Â
    • ÀçÅà Äɾî Ä¡·á ±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • È£Èí±â°è¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¨¿°ÁõÀÇ À¯Çà
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºÒ¸®ÇÑ »óȯ Á¤Ã¥
  • ½ÃÀå ±âȸ
    • È£Èí Áö¿ø ½Ã½ºÅÛÀÇ ±â¼ú Áøº¸
    • POC(Point of Care) Áø´ÜÀÇ º¸±Þ
  • ½ÃÀå °úÁ¦
    • ƯÁ¤ ±â±â¿¡ ÀÇÇÑ ½Å»ý¾Æ¿¡ ´ëÇÑ À¯ÇØÇÑ ¿µÇâ

Porter's Five Forces : È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ºñÁî´Ï½º Á¶Á÷ÀÌ °æÀïÀû À§Ä¡¸¦ Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ý·ÐÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÈûÀÇ ¿ªÇÐ °ü°è¸¦ Æò°¡ÇÏ°í »õ·Î¿î º¥Ã³ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϸç ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¹æÁöÇÏ¿© º¸´Ù ź·ÂÀûÀÎ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú, ¹ý·ü ¹× ȯ°æ ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ¿© ¼±Á¦ÀûÀÌ°í ¹Ì·¡ ÁöÇâÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï ¿ìÀ§¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­, ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© º¥´õ°¡ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀº °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ±Û·Î¹ú ½ÃÀå ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø ¹× Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • È£Èí±â ÁúȯÀÇ ÀÌȯÀ² »ó½Â
      • ÀçÅÃÄ¡·á±â±â ¼ö¿ä Áõ°¡
      • È£Èí±â°è¿¡ ¿µÇâÀ» ÁÖ´Â °¨¿°ÁõÀÇ ¹ß»ý
    • ¾ïÁ¦¿äÀÎ
      • ºÒ¸®ÇÑ È¯ºÒ Á¤Ã¥
    • ±âȸ
      • È£Èí Áö¿ø ½Ã½ºÅÛÀÇ ±â¼ú Áøº¸
      • POC(Point of Care) Áø´ÜÀÇ Àαâ Áõ°¡
    • °úÁ¦
      • ƯÁ¤ ±â±â°¡ ½Å»ý¾Æ¿¡ ¹ÌÄ¡´Â À¯ÇØÇÑ ¿µÇâ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå : ÀûÀÀÁõº°

  • õ½Ä
  • ¸¸¼º Æó»ö¼º ÆóÁúȯ
  • °¨¿°Áõ
  • ¼ö¸é½Ã ¹«È£ÈíÁõÈıº

Á¦7Àå È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • ¼Ò¸ðǰ ¹× ¾×¼¼¼­¸®
    • ÀÏȸ¿ë ÀΰøÈ£Èí±â
    • ¸¶½ºÅ©
    • ÄÚ Ä³´¼¶ó
    • ±â°üÀý°³Æ©ºê
  • Áø´Ü ÀåÄ¡
    • ÇÇÅ© À¯·®°è
    • ¼ö¸é´Ù¿ø°Ë»ç ÀåÄ¡
    • ½ºÆÄÀ̷ιÌÅÍ
  • ¸ð´ÏÅ͸µ ÀåÄ¡
    • »ê¼Ò Æ÷È­µµ ÃøÁ¤±â
    • °¡½ººÐ¼®ÀåÄ¡
    • ¸Æ¹Ú »ê¼Ò ÃøÁ¤±â
  • Ä¡·á±â±â
    • °¡½À±â
    • ÈíÀÔ±â
    • ³×ºæ¶óÀÌÀú
    • »êÈ­Áú¼Ò Àü´Þ ÀåÄ¡
    • »ê¼Ò ³óÃà±â
    • »ê¼Ò Èĵå
    • PAP µð¹ÙÀ̽º
    • Àç»ç¿ë °¡´ÉÇÑ ÀΰøÈ£Èí±â
    • ÀΰøÈ£Èí±â

Á¦8Àå È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡ Áø·á ¼¾ÅÍ
  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« È£Èí Áö¿ø ½Ã½ºÅÛ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Ãßõ

±â¾÷ ¸ñ·Ï

  • Air Liquide SA
  • Allied Healthcare Products, Inc.
  • APEX Medical Corp.
  • Drive deVilbiss Healthcare
  • Dragerwerk AG&Co. KGaA
  • Fisher&Paykel Healthcare Corporation Limited
  • General Electric Company
  • Getinge AB
  • Hamilton Company
  • HERSILL, SL
  • Invacare Corporation
  • Masimo Corporation
  • Medtronic PLC
  • Nihon Kohden Corporation
  • Omron Corporation
LYJ

The Respiratory Support System Market was valued at USD 28.92 billion in 2023, expected to reach USD 31.71 billion in 2024, and is projected to grow at a CAGR of 9.73%, to USD 55.42 billion by 2030.

The respiratory support system market encompasses a wide range of devices and equipment designed to aid or replace respiratory functions for patients with compromised pulmonary capabilities. These systems include ventilators, CPAP devices, BiPAP devices, and oxygen concentrators, each serving critical roles in managing respiratory insufficiency or failure due to conditions such as chronic obstructive pulmonary disorder (COPD), sleep apnea, and acute respiratory distress syndrome (ARDS). The necessity for these systems has been amplified by the increasing prevalence of respiratory diseases, aging populations, and recent public health crises like COVID-19, which necessitated rapid scaling of respiratory support capacities in healthcare settings. Additionally, these devices find applications across homecare settings, hospitals, and ambulatory centers, broadening their end-use scope.

KEY MARKET STATISTICS
Base Year [2023] USD 28.92 billion
Estimated Year [2024] USD 31.71 billion
Forecast Year [2030] USD 55.42 billion
CAGR (%) 9.73%

Market growth is driven by technological advancements such as the integration of AI and IoT for improved patient monitoring and device automation. Furthermore, expanding healthcare infrastructure in emerging economies presents significant growth opportunities. However, challenges such as high costs of advanced systems, stringent regulatory approvals, and the complexity of device operation in less developed healthcare facilities pose hurdles to market expansion. Key growth-limiting factors include prolonged approval times and reimbursement issues which can deter market entry for new players.

The best areas for innovation and research include developing portable and user-friendly devices, enhancing telehealth integration for remote monitoring, and designing systems that offer personalized respiratory support through data analytics and AI. These innovations are crucial to maintaining market competitiveness and addressing unmet clinical needs. Strategic collaborations with tech companies can facilitate this innovation. The market is currently dynamic, characterized by rapid advancements and competitive pressures; understanding the nuances in regulatory requirements, cost-benefit analyses, and technological trends is essential for gaining a competitive edge and ensuring sustainable growth in this high-demand sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Respiratory Support System Market

The Respiratory Support System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of respiratory diseases
    • Growing demand for homecare therapeutics devices
    • Outbreak of infections diseases affecting the respiratory system
  • Market Restraints
    • Unfavorable reimbursement policies
  • Market Opportunities
    • Technological advancement in respiratory support system
    • Growing popularity of Point-of-Care diagnosis
  • Market Challenges
    • Harmful effects of certain devices on neonates

Porter's Five Forces: A Strategic Tool for Navigating the Respiratory Support System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Respiratory Support System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Respiratory Support System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Respiratory Support System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Respiratory Support System Market

A detailed market share analysis in the Respiratory Support System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Respiratory Support System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Respiratory Support System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Respiratory Support System Market

A strategic analysis of the Respiratory Support System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Support System Market, highlighting leading vendors and their innovative profiles. These include Air Liquide S.A., Allied Healthcare Products, Inc., APEX Medical Corp., Drive deVilbiss Healthcare, Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, General Electric Company, Getinge AB, Hamilton Company, HERSILL, S.L., Invacare Corporation, Masimo Corporation, Medtronic PLC, Nihon Kohden Corporation, and Omron Corporation.

Market Segmentation & Coverage

This research report categorizes the Respiratory Support System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Asthma, Chronic Obstructive Pulmonary Disease, Infectious Diseases, and Sleep Apnea.
  • Based on Product, market is studied across Consumables & Accessories, Diagnostic Devices, Monitoring Devices, and Therapeutic Devices. The Consumables & Accessories is further studied across Disposable Resuscitators, Masks, Nasal Cannulas, and Tracheostomy Tubes. The Diagnostic Devices is further studied across Peak Flow Meters, Polysomnography Devices, and Spirometers. The Monitoring Devices is further studied across Capnographs, Gas Analyzers, and Pulse Oximeters. The Therapeutic Devices is further studied across Humidifiers, Inhalers, Nebulizers, Nitric Oxide Delivery Units, Oxygen Concentrators, Oxygen Hoods, PAP Devices, Reusable Resuscitators, and Ventilators.
  • Based on End User, market is studied across Ambulatory Care Centers, Home Care Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of respiratory diseases
      • 5.1.1.2. Growing demand for homecare therapeutics devices
      • 5.1.1.3. Outbreak of infections diseases affecting the respiratory system
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement policies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in respiratory support system
      • 5.1.3.2. Growing popularity of Point-of-Care diagnosis
    • 5.1.4. Challenges
      • 5.1.4.1. Harmful effects of certain devices on neonates
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Respiratory Support System Market, by Indication

  • 6.1. Introduction
  • 6.2. Asthma
  • 6.3. Chronic Obstructive Pulmonary Disease
  • 6.4. Infectious Diseases
  • 6.5. Sleep Apnea

7. Respiratory Support System Market, by Product

  • 7.1. Introduction
  • 7.2. Consumables & Accessories
    • 7.2.1. Disposable Resuscitators
    • 7.2.2. Masks
    • 7.2.3. Nasal Cannulas
    • 7.2.4. Tracheostomy Tubes
  • 7.3. Diagnostic Devices
    • 7.3.1. Peak Flow Meters
    • 7.3.2. Polysomnography Devices
    • 7.3.3. Spirometers
  • 7.4. Monitoring Devices
    • 7.4.1. Capnographs
    • 7.4.2. Gas Analyzers
    • 7.4.3. Pulse Oximeters
  • 7.5. Therapeutic Devices
    • 7.5.1. Humidifiers
    • 7.5.2. Inhalers
    • 7.5.3. Nebulizers
    • 7.5.4. Nitric Oxide Delivery Units
    • 7.5.5. Oxygen Concentrators
    • 7.5.6. Oxygen Hoods
    • 7.5.7. PAP Devices
    • 7.5.8. Reusable Resuscitators
    • 7.5.9. Ventilators

8. Respiratory Support System Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Home Care Settings
  • 8.4. Hospitals

9. Americas Respiratory Support System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Respiratory Support System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Respiratory Support System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Air Liquide S.A.
  • 2. Allied Healthcare Products, Inc.
  • 3. APEX Medical Corp.
  • 4. Drive deVilbiss Healthcare
  • 5. Dragerwerk AG & Co. KGaA
  • 6. Fisher & Paykel Healthcare Corporation Limited
  • 7. General Electric Company
  • 8. Getinge AB
  • 9. Hamilton Company
  • 10. HERSILL, S.L.
  • 11. Invacare Corporation
  • 12. Masimo Corporation
  • 13. Medtronic PLC
  • 14. Nihon Kohden Corporation
  • 15. Omron Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦